Nexomics

🚀 Our Lead Scientist in Immunology Clinical Trials, Nitasha Kumar, along with our research flow team at Peter MacCallum Cancer Centre, is attending the Australasian Cytometry Society Conference (ACS Conference 2024) over the next few days. This event is dedicated to advancing cytometry research, development, applications, and knowledge across Australia. 🌏🔬🌟 Nitsha looking forward to connecting with our suppliers and fellow researchers, and expanding our knowledge in this key area of clinical trial testing. #ACS2024 #FlowCytometry #Oncology #CancerResearch #ClinicalTrials #Innovation

A liquid biopsy test for Cancer of Unknown Primary (CUP) in development ⏳ 🎯🩸 #WatchThisSpace #LiquidBiopsy #Oncology #PrecisionMedicine #CUP

Are you a science enthusiast who loves diving deep into the world of clinical trials and immunology? Do you thrive in dynamic environments and want to make a real impact in cancer research? 🌍💡   Nexomics Immunology Team, part of Peter MacCallum Cancer Centre, led by the talented Nitasha Kumar, is on the lookout for a passionate Scientist to join our cutting-edge Clinical Trials team at the VCCC in Parkville! 🏥🔬   Here’s what you’ll be contributing to:    🧫 Process and analyse samples in clinical immunology / flow cytometry, adhering to GLP and ICH-GCP standards 🧪 Validate new tests, contribute to global clinical trials, and help innovate new methodologies 🛠 Maintain lab equipment, manage supplies, and uphold top-notch quality standards 💬 Collaborate with a dynamic scientific, clinical team and global sponsors to drive groundbreaking clinical trials 🎯 Who are we looking for? 🔬 Medical Scientist (Part-Time) with experience in clinical immunology and flow cytometry 🗣 Excellent communication skills to keep everything running smoothly 💡 An enthusiastic team player who thrives on collaboration Join us and be part of something bigger: changing lives, breaking new ground, and pushing the boundaries of cancer care. 🙌💥   #sciencecareers #pathology #clinicaltrials #flowcytometry #immunology #innovation #hiring #jobopportunity   Ready to change the game? Apply now! 🌱🔬 https://lnkd.in/gzHMRjkR

Don’t stop at BRAF V600E.. When DNA sequencing for BRAF/MAP2K1/KRAS/NRAS mutations is negative in the workup of #histiocytoses.. start thinking about gene fusions (actually preferable to start thinking about fusions from the start!)... Below is a KIF5B::ALK fusion from targeted RNA-sequencing making a diagnosis of this entity - https://lnkd.in/g6sKjqEP Clinicopathological features of this rare disease (ALK-positive histiocytosis) -         Presentation any time from infant to adult -         Can be single system (most often CNS) or multisystem involvement (CNS, bone, lungs..) -         Bone lesions can look like Erdheim-Chester disease -         Beware – ALK IHC may show dot-like positivity that may be interpreted as negative.. - Almost always ALKex20 fused to KIF5Bex24 MOST IMPORTANTLY..  like almost all histiocytoses… targeted inhibition of molecular driver is remarkably effective and the therapy of choice. Multiple ALK inhibitors have been used in this entity (#crizotinib, #alectinib, #lorlatinib, #brigatinib, #ceritinib..) - 100% response rate (!) in the above linked work. #WilsonCentreforBloodCancerGenomics #PrecisionDiagnostics #AllHaemRNA #FusionPanels #hemepath #NGS 

🎉Celebrating Aussie biotech innovation with Aussie hospitality at #BIO2024! Thanks to the generous support of Global Victoria, Investment NSW, Trade and Investment Queensland, Department for Trade and Investment and Department of Jobs, Tourism, Science and Innovation! Stuart Dignam, Hon. Jaala Pulford, Ed Husic MP, Ken Wyatt AM, CSIRO WA Life Sciences Innovation Hub, MTPConnect Adelaide Intermediary Program, Jo Close, Tamlyn O'Connor, Jo Glew, Caroline Duell, Tracey Wilkinson, Jarrod Belcher GAICD, Australian Trade and Investment Commission (Austrade), AusBiotech

Full steam ahead in San Diego for our Nexomics team who have been exploring the thriving biotech hub and all that it has to offer - We wish our team all the best over the coming days at #BIO2024, creating memories, connections and showcasing the best of Peter MacCallum Cancer Centre and our incredible diagnostic offerings. A huge thanks to Global Victoria and MTPConnect teams for your ongoing support. #TheAustralianAdvantage #Collaboration #Partnerships #Innovation #ClinicalTrials #Oncology #PrecisionMedicine

Our Commercialisation and Business Development teams are en-route to San Diego for this years #BIO2024 International Convention where we will be focussed on our incredible suite of specialised oncology assays to support your diagnostics and clinical trial developments. #ClinicalTrials #Oncology #PrecisionOncology #PrecisionMedicine

🎉 Happy International Nurses Day! 🎉 Today, we celebrate the unwavering dedication, compassion, and expertise of nurses - both past and present - who have contributed to 75 years of exceptional patient care at Peter Mac. Tomorrow we will recognise their outstanding contributions at our Nursing Awards and we look forward to sharing the winners and their stories with you. To every nurse out there, THANK YOU! #InternationalNursesDay #ThankYouNurses

After an enriching journey across Europe, our Peter MacCallum Cancer Centre and Nexomics Business Development Teams are now homeward bound, brimming with insights and inspiration.   Paris and Barcelona treated us to a whirlwind of innovation and partnership opportunities. With our Global Victoria delegation, we delved into the bustling streets of Paris for this year’s BIO-EUROPE SPRING Victorian Trade Mission, and it surpassed all expectations!   Our mission was clear: to amplify Victoria’s vibrant life sciences and biotechnology industry while forging stronger bonds between France and Australia. Immersed in the thriving Parisian innovation ecosystem, we explored a multitude of avenues for growth and partnership.   Our European escapade unfolded like a mesmerising symphony... From the historic charm of Hôtel-Dieu de France to the innovation hub of BioLabs France, each stop enriched our understanding of the French healthcare landscape. At Genopole, we witnessed firsthand the intersection of research and commercialisation, while Paris-Saclay unveiled the dynamic spirit of technological innovation. France's biotech industry emerged as a garden of possibilities, meticulously nurtured to yield both patient-centric and commercial successes.   Onward to Barcelona, BIO-EUROPE Spring, where our teams engaged and connected with the European Biopharma community exploring opportunities for partnership. _   As we bid adieu to Europe, we are filled with gratitude and appreciation for the enriching experiences & promising partnerships forged along the way.   A heartfelt thank you goes out to the masterminds behind this mission—Gönül Serbest, Stuart Bland, Anne Hiag, Léonore Marteville, Anne-Sophie Boulet, and Amanda Caples—for their unwavering support throughout.   A big thank you to Yann Masson Silvia Paolella and Chloe Evans who laid the initial groundwork in introducing the Paris region and to Fanny Ligier for offering extended support in the region.   To our fellow Victorian delegates—Angela Luttick, Dr Michael Andrews Luke, Lucy Pearce, Helen P., Robin Hansen, Anne De Luca, Shane Ryan, Kurt Lackovic, Magnus Ahlström, Janet Yeo, Catherine Osborne PhD GAICD, and —it was an absolute pleasure to share this transformative journey with you all. Your steadfast commitment to advancing science within our region is truly commendable. Special thanks to Dr. Pavel Reddy for his invaluable connections and insights.   #GlobalVictoria #Oncology #Innovation #Partnerships #ClinicalTrials #HealthcareInnovation #bioeuropespring2024   Peter MacCallum Cancer Centre; Nexomics; Cancer Trials Australia; 360biolabs, a BioAgilytix company; Molecule2Market; Aliquot Solutions; Hydrix; Formulytica Australian Trade and Investment Commission (Austrade)   [Source images courtesy of the Australian Embassy, Global Victoria]

🌟 Elevating Life Science Partnerships at BIO-EUROPE SPRING in Barcelona! 🇪🇸 In the heart of Barcelona, where Gaudí’s architectural wonders meet the Mediterranean breeze, something extraordinary is unfolding. The BIO-EUROPE SPRING, Europe’s premier springtime partnering event, has cast its spell on the global biopharma community and our Business Development teams from Peter MacCallum Cancer Centre and Nexomics engaging and connecting with the European Biopharma community together with our powerhouse of Global Victoria colleagues and partners. #precisiononcology #oncology #clinicaltrials